Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Cybersecurity (BUG) vs Medpace Holdings Inc (MEDP) Price & Performance

Global X CybersecurityTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

Global X Cybersecurity vs Medpace Holdings Inc — how do they compare? Global X Cybersecurity trades at $42.93, while Medpace Holdings Inc trades at $605.78 (market cap $16.81B). Which is the better fit depends on your goals.

BUGMEDP
Sector
Sector/ThematicTechnology
52-Week High
$43.00$620.59
52-Week Low
$23.30$393.42
Market Cap
$16.81B
Enterprise Value
$16.43B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Cybersecurity

BUG, the Global X Cybersecurity ETF, trades at $41.68, up 2.36% today and near its 52-week high, with a strong bullish technical signal from moving averages. The ETF has gained significant momentum, rising 82.25% from its 52-week low, as cybersecurity spending forecasts exceed $300 billion in 2026. Recent news highlights sector resilience against AI threats, though key financial ratios like P/E and P/S are not provided in the available data.

The outlook for BUG is positive, driven by robust cybersecurity demand and AI-related security needs, but risks include premium valuations, concentrated US SMID-cap exposure, and potential sector volatility. Analyst sentiment remains bullish with reiterated buy ratings, yet investors should note overbought short-term signals and competitive pressures in the evolving tech landscape.

Medpace Holdings Inc

MEDP trades at $590.67, up 0.97% on the day, near its consensus price target of $599.57. The stock shows bullish momentum with a golden cross formation and strong institutional interest, while recent Q2 2026 earnings beat estimates with EPS of $4.25 versus $3.98 expected. Revenue growth remains robust, projected to rise from $2.53 billion in 2025 to $2.8 billion in 2026, supporting a premium valuation with a P/E of 35.4.

Outlook is positive given earnings consistency and raised 2026 guidance, but risks include high valuation sensitivity and a shareholder lawsuit investigation. The stock offers growth potential from a strong backlog and net book-to-bill ratio of 1.13x, though investors should monitor legal developments and competitive pressures in medical services.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Global X Cybersecurity

BUG is a thematic ETF that invests in companies at the forefront of the global cybersecurity industry. It provides concentrated exposure to leaders in network security, endpoint protection, and cloud security, such as Fortinet, Akamai, and CrowdStrike.

Read more on BUG

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP